Unique ID issued by UMIN | UMIN000024792 |
---|---|
Receipt number | R000028524 |
Scientific Title | Study for utility of fecal microbiota transplantation for graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. |
Date of disclosure of the study information | 2016/11/11 |
Last modified on | 2018/11/20 21:54:09 |
Study for utility of fecal microbiota transplantation for graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
GVHDFMT
Study for utility of fecal microbiota transplantation for graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
GVHDFMT
Japan |
graft-versus-host disease after allogeneic hematopoietic stem cell
Gastroenterology | Hematology and clinical oncology | Blood transfusion |
Others
NO
We examine a utility eight weeks after FMT for GVHD after allogeneic hematopoietic stem cell transplantation.
We think about whether FMT may become the choice of GVHD after new allogeneic hematopoietic stem cell transplantation of GVHD.
Safety,Efficacy
Confirmatory
Explanatory
Not applicable
A utility eight weeks after FMT for GVHD after allogeneic hematopoietic stem cell transplantation.
A safety eight weeks after FMT for GVHD after allogeneic hematopoietic stem cell transplantation.
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Maneuver |
FMT
20 | years-old | <= |
65 | years-old | > |
Male and Female
Presence or absence of primary therapy and steroid-resistant or steroid-dependent presence do not matter.
(2) Age is one younger than 65 years 20 years old or older.
(3) Performance status (PS) is 0, 1, 2 patients.
(4) About participation in this study, as for the person.
It can be a provider (donor) an agreement is obtained from one, following.
(1) It is a person within the third degree from a study participant (recipients)
(2) It is a person until 65 years old 20 years old or older
(3) The one that can have you offer feces 200 g or more on the day of transplantation
(1) A blood test: HIV, HTLV-1, syphilis, liver dysfunction, hepatitis A, hepatitis B, hepatitis C, cytomegalovirus, EB virus, amoebic dysentery
(2) A feces examination: Helicobacter pylori, Yersinia, Campylobactor, dysentery, Salmonella, hemorrhagic enteropathic E.coli, rotavirus, adenovirus, norovirus, parasitic worm screening, ova of parasites screening, Clostridium difficile (CD toxin A/B)
10
1st name | |
Middle name | |
Last name | Hirotsugu Imaeda |
Shiga University of Medical Science
Division of Gastroenterology, Department of Medicine
Setatsukinowa, Otsu
077-548-2217
imaeda@belle.shiga-med.ac.jp
1st name | |
Middle name | |
Last name | Hirotsugu Imaeda |
Shiga University of Medical Science
Division of Gastroenterology, Department of Medicine
Setatsukinowa, Otsu
077-548-2217
http://www.ninai-sums.jp/study/gastrointestinal-medicine
imaeda@belle.shiga-med.ac.jp
Shiga University of Medical Science
Ministry of Health, Labour and Welfare
Japanese Governmental office
NO
2016 | Year | 11 | Month | 11 | Day |
Unpublished
Enrolling by invitation
2016 | Year | 11 | Month | 11 | Day |
2016 | Year | 11 | Month | 11 | Day |
2019 | Year | 03 | Month | 31 | Day |
2019 | Year | 03 | Month | 31 | Day |
2019 | Year | 03 | Month | 31 | Day |
2019 | Year | 03 | Month | 31 | Day |
2016 | Year | 11 | Month | 10 | Day |
2018 | Year | 11 | Month | 20 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028524
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |